Mr. George L. Sing is Co-Founder, Chairman, CEO of GanD, Inc. He has been a venture capital investor in seed/early stage start-ups in healthcare and high technology with extensive operational and financial expertise and executive leadership experience. Mr. Sing was a co-founder of Merrill Lynch Venture Capital, Inc., Advanced Technology Ventures and Lancet Capital. He was co-founder, Executive Chairman of Stentor, Inc. (acquired by Philips) and co-founder, CEO of Stemnion, Inc. Mr. Sing has been a Director at Regeneron Pharmaceuticals, Inc. since inception when he was the seed/start-up investor for Merrill Lynch Venture Capital. He received a Master of Business Administration degree from Harvard Business School and Bachelor of Engineering degree from Stevens Institute of Technology.